SII is pursuing approval for the Covishield as a booster dose due to concerns of Omicron

Serum Institute resumes the supply of Covishield under COVAX programme

In April, the Centre halted supplies of Covid-19 vaccinations to the UN-backed programme.

New Zealand adds Covaxin, Covishield to list of recognised Covid-19 vaccines

After Australia, its New Zealand has recognied Covaxin and Covishield, the two most widely-used vaccines in India's vaccination drive

New covid travel rules in UK from today

In a piece of good news for travellers from India, fully vaccinated Indians with Covishield or any other UK-approved vaccine travelling to the UK will not have to undergo quarantine from Monday

Delhi Govt: Reserves 40% Covaxin stock and 20% Covishield jabs for 1st shot

This set up will be in place till the vaccine supply situation improves in the national capital.

NTAGI Chairman: Decision to increase gap between Covishield doses based on scientific evidence

Dr NK Arora on Wednesday stated that the decision to increase the gap between two Covishield doses from 4-6 weeks to 12-16 weeks is based on "fundamental scientific reasons"

Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's Covaxin price

Hyderabad-based vaccine maker Bharat Biotech on Tuesday said the current supply price of its Covid-19 vaccine Covaxin to the Centre is not sustainable in the long run.

Vaccine ready for 12+, Pfizer tells centre, seeks fast-track approval

Gujarat: Vaccination for above 45 age group suspended for three days

Karnataka to get 2 crore COVID-19 vaccine doses through global tender